Hemostemix Inc. is pleased to announce that Stem Cell Research & Therapy published the Company s seventh peer reviewed study of ACP-01 - the third peer reviewed study of ACP-01 as a treatment for.
Hemostemix Inc. is pleased to announce it has amended its $2.5 million 5 year convertible debenture, which originally closed on June 11, 2021 resulting in an expected interest saving of.
Hemostemix Inc. (CVE:HEM – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.13 and traded as low as C$0.11. Hemostemix shares last traded at C$0.12, with a volume of 53,500 shares changing hands. Hemostemix Trading Down 4.2 […]
Hemostemix Inc.: Hemostemix Closed $320,125 Private Placement finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Hemostemix Closed $320,125 Private Placement marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.